FDA approves first U.S. treatment benznidazole for Chagas disease
FDA approves first U.S. treatment for Chagas disease 08/29/2017 The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease. The U.S. Food and …